SCHEMBL2825650

SCHEMBL2825650

CCc1cc(C2=CC=C(c3ccc(OCC4CO4)cc3)CC2)ccc1OCC1CO1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
TP53 P04637 3/20 0.44
TSHR P16473 3/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 2/20 0.44
PKM P14618 2/20 0.44
HIF1A Q16665 2/20 0.44
CYP1A2 P05177 1/20 0.44
PPARG P37231 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
TDP1 Q9NUW8 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
CYP3A4 P08684 1/20 0.41
GLA P06280 1/20 0.40
VDR P11473 1/20 0.38
PTPN1 P18031 1/20 0.35
NPC1 O15118 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2719657 0.91 PPARG (0.42) ALDH1A1TP53TSHRMEN1KMT2A
SCHEMBL2720091 0.89 ALDH1A1 (0.43) ALDH1A1TP53TSHRMEN1KMT2A
SCHEMBL2718619 0.89 ALDH1A1 (0.49) ALDH1A1TP53TSHRMEN1KMT2A
SCHEMBL2719240 0.89 ALDH1A1 (0.40) ALDH1A1TP53TSHRMEN1KMT2A
SCHEMBL2825931 0.88 ALDH1A1 (0.40) ALDH1A1TP53TSHRMEN1KMT2A
SCHEMBL2827505 0.87 ALDH1A1 (0.39) ALDH1A1TP53TSHRMEN1KMT2A
SCHEMBL2828733 0.87 ALDH1A1 (0.39) ALDH1A1TP53TSHRMEN1KMT2A
SCHEMBL2719614 0.87 ALDH1A1 (0.39) ALDH1A1TP53TSHRMEN1KMT2A
SCHEMBL2719342 0.86 ALDH1A1 (0.49) ALDH1A1TP53TSHRMEN1KMT2A
SCHEMBL2829473 0.83 ALDH1A1 (0.40) ALDH1A1TP53TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160555-A1 RESIN COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-24 US disclosed
US-20100144926-A1 EPOXY RESIN COMPOSITION SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-10 US disclosed
EP-2133380-A1 RESIN COMPOSITION Sumitomo Chemical Company, Limited (JP) 2009-12-16 EP disclosed
EP-2133379-A1 EPOXY RESIN COMPOSITION Sumitomo Chemical Company, Limited (JP) 2009-12-16 EP disclosed
US-20090054669-A1 Process For Producing Epoxy Compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-02-26 US disclosed
US-20090018355-A1 Process for Crystallizing an Epoxy Compound SUMITOMO CHEMICAL COMPANY, LTD. 2009-01-15 US disclosed
EP-1995245-A1 METHOD FOR PRODUCING EPOXY COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-11-26 EP disclosed
EP-1995244-A1 METHOD FOR CRYSTALLIZATION OF EPOXY COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-11-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018355-A1 Process for Crystallizing an Epoxy Compound PTGER1, NR5A1, TCP1 ALDH1A1 938/4885TP53 3527/4885TSHR 1136/4885
US-20090054669-A1 Process For Producing Epoxy Compound RER1, AR, CYP1A1 ALDH1A1 464/4885TP53 4049/4885TSHR 2772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.